The New York Times is running an interesting piece on embryonic stem cell research, therapeutic cloning and the goals of researchers in the field. "Another group directed mouse stem cells to grow into nerve cells and tried to use them to treat Parkinson's disease in mice. The nerve cells produced the missing chemical, dopamine, but not enough to cure the disease ... use the cells instead of bone marrow transplants to treat patients with genetic disorders like sickle cell anemia, and inborn disorders of the immune system ... goal in cloning is to understand what goes wrong in a disease like Alzheimer's, Parkinson's or diabetes." This is an energetic, very promising field that would benefit greatly from an end to restrictive legislation and threats of criminalization.
24
Aug
2004
NYT On Embryonic Stem Cell Research
Comments
Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.
First Steps
The Causes of Aging
- Accumulating AGEs
- Buildup of Amyloid Between Cells
- The Failing Adaptive Immune System
- The Failing Innate Immune System
- Declining Lysosomal Function
- Mitochondrial DNA Damage
- Nuclear DNA Damage
- Buildup of Senescent Cells
- Other Causes of Aging
Archives and Feeds
- Monthly News and Blog Archives
- Newsletter Archive
- Using the Fight Aging! Content Feeds
- Fight Aging! on the Kindle
Required Reading
- Calorie Restriction
- The Community, Visualized
- Cryonics
- Engineered Negligible Senescence
- Envisaging a World Without the FDA
- How to Argue for Longevity Science
- Introductory Articles
- The Odds of Human Longevity Mutations
- The Need For Activism and Advocacy
- Stem Cells, Regenerative Medicine
- Twelve Ways to Extend Mouse Life Span
- Transhumanism and Human Longevity
- The Vital Debate in Aging Research
- What is Anti-Aging?
Creative Commons
- All of Fight Aging!, with the exception of the introductory articles, is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Creative Commons licensed Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.